Latest news with #ProductionLinkedIncentives
Hans India
3 days ago
- Business
- Hans India
AP showcases investment potential in electronics manufacturing
Tirupati: Andhra Pradesh is fast emerging as a prime destination for investments and industrial growth, especially in the electronics manufacturing sector. The Electronics Component Manufacturing Scheme (ECMS) and Andhra Pradesh Electronics Component Manufacturing Policy draft workshop in Tirupati held on Thursday was aimed at giving a further boost to this sector. The one-day workshop was jointly organised by the IT, Electronics & Communications (ITE&C) Department, AP Economic Development Board, and the India Cellular and Electronics Association. The workshop saw participation from key dignitaries including Sushil Pal, Joint Secretary of the Ministry of Electronics and IT, who stated that the Government of India is actively promoting electronics component manufacturing through Production Linked Incentives (PLI) and other incentives. He lauded AP's proactive efforts and underlined the strong demand for electronics components in the market. Speaking at the event, Secretary of ITE&C Bhaskar Katamneni highlighted that the state government under the leadership of the Chief Minister is committed not only to 'Ease of Doing Business' but also to 'Speed of Doing Business.' He emphasised the abundant opportunities in the state for setting up industries and expressed confidence that Andhra Pradesh is crafting a more competitive and investor-friendly electronics policy compared to the Central Government's framework. Bhaskar revealed that the state is aiming to localise production of electronic components, which are currently being imported, and is formulating a forward-looking policy to attract manufacturers. Plans are already underway to establish 25 percent of these units in the southern Rayalaseema region. Tirupati EMC-2 cluster and the Kopparthy EMC are being positioned as key hubs for this expansion. Highlighting the state's industrial readiness, he mentioned Sri City, where more than 200 industries are operational and contributing to significant employment. Andhra Pradesh boasts superior infrastructure with robust road, rail, airport, and port connectivity. Reaffirming the state's commitment to transparency and technological governance, he said Andhra Pradesh is leveraging AI, IoT, drones, and WhatsApp governance for effective administration. As the state works toward its Vision 2047 goal of becoming a $2.4 trillion economy, it aims to harness not just IT but a range of industrial sectors to meet national targets.
Time of India
28-05-2025
- Automotive
- Time of India
EV two-wheeler sales soared 34x in 4 years, but market share stuck at 4%: Study
Electric vehicle (EV) sales in India have grown rapidly across segments in the last decade, but adoption rates remain modest despite significant fiscal support, a new study by the Institute for Energy Economics and Financial Analysis (IEEFA) has found. The report, From Incentives to Adoption, presents a 10-year review (2014–2023) of government subsidies and policy interventions under FAME-I, FAME-II, Production Linked Incentives (PLI), and state schemes, and assesses their effectiveness across five EV segments. In the electric two-wheeler (E2W) segment, sales jumped from 19,333 units in FY2019 to over 6.5 lakh units in FY2023. However, the adoption rate – the share of electric vehicles in overall two-wheeler sales – was only 4% by the end of 2023. 'FAME-II's higher subsidy intensity (28.65%) compared to FAME-I (14.32%) boosted absolute E2W sales by up to 9 times, but had limited impact on the overall market composition,' the report states. According to Charith Konda, Energy Specialist at IEEFA and one of the co-authors, 'The government should continue offering purchase subsidies to sustain momentum but clearly communicate a phased-down trajectory for the longer term.' In the electric three-wheeler passenger (E3WP) segment, early policy support under FAME-I drove a 10x market multiplier effect. Around 27,000 additional vehicles were directly attributed to subsidies under FAME-I, with total sales reaching 2.67 lakh units by March 2019. The segment, however, matured during the FAME-II period and showed limited incremental impact from later subsidies. The electric three-wheeler cargo (E3WC) category saw a market share rise from 0.03% in 2015 to over 31% by 2023. The study found this growth was largely driven by operating cost advantages rather than central subsidies. A 1% reduction in operating cost led to a 0.563% increase in sales, highlighting the role of business economics in commercial segments. In the electric four-wheeler commercial (E4WC) category, sales improved after FAME-II and PLI schemes were implemented. A one-standard-deviation increase in subsidy intensity led to a 5% rise in sales. However, the adoption rate was still less than 1%. States that implemented incentives saw 211% higher sales growth than those that did not. For electric four-wheelers in the private segment (E4WP), sales grew due to new model launches and consumer demand, but adoption rates remained below 2%. The report highlights the need for continuing support in this segment. The report found that both FAME-I and FAME-II failed to make a statistically significant impact on electric bus (e-bus) adoption. Only 4,766 units were subsidised against a target of 7,262, and the sector continues to face structural barriers such as limited financing access and high upfront costs. 'Coordinated central and state action, pairing targeted purchase incentives, infrastructure rollout, and manufacturing scale-up can help electric cars compete effectively with their counterparts in India's commercial vehicle market,' said Saurabh Trivedi, Sustainable Finance Specialist at IEEFA. The study recommends continued fiscal support, investment in public charging infrastructure, interest rate subvention for buses, and targeted financing support for smaller commercial operators. 'As India transitions from FAME schemes to PM E-DRIVE and other similar initiatives, policymakers must recognise that each EV segment requires tailored intervention,' Konda added. The report draws on panel data of 21,526 observations over 10 years, offering a first-of-its-kind empirical assessment of India's EV subsidy performance using econometric techniques such as difference-in-differences and synthetic control methods.
Time of India
28-05-2025
- Automotive
- Time of India
EV two-wheeler sales soared 34x in 4 years, but market share stuck at 4%: Study
New Delhi: Electric vehicle (EV) sales in India have grown rapidly across segments in the last decade, but adoption rates remain modest despite significant fiscal support, a new study by the Institute for Energy Economics and Financial Analysis (IEEFA) has found. The report, From Incentives to Adoption, presents a 10-year review (2014–2023) of government subsidies and policy interventions under FAME-I, FAME-II, Production Linked Incentives (PLI), and state schemes, and assesses their effectiveness across five EV segments. In the electric two-wheeler (E2W) segment, sales jumped from 19,333 units in FY2019 to over 6.5 lakh units in FY2023. However, the adoption rate – the share of electric vehicles in overall two-wheeler sales – was only 4% by the end of 2023. 'FAME-II's higher subsidy intensity (28.65%) compared to FAME-I (14.32%) boosted absolute E2W sales by up to 9 times, but had limited impact on the overall market composition,' the report states. According to Charith Konda, Energy Specialist at IEEFA and one of the co-authors, 'The government should continue offering purchase subsidies to sustain momentum but clearly communicate a phased-down trajectory for the longer term.' In the electric three-wheeler passenger (E3WP) segment, early policy support under FAME-I drove a 10x market multiplier effect. Around 27,000 additional vehicles were directly attributed to subsidies under FAME-I, with total sales reaching 2.67 lakh units by March 2019. The segment, however, matured during the FAME-II period and showed limited incremental impact from later subsidies. The electric three-wheeler cargo (E3WC) category saw a market share rise from 0.03% in 2015 to over 31% by 2023. The study found this growth was largely driven by operating cost advantages rather than central subsidies. A 1% reduction in operating cost led to a 0.563% increase in sales, highlighting the role of business economics in commercial segments. In the electric four-wheeler commercial (E4WC) category, sales improved after FAME-II and PLI schemes were implemented. A one-standard-deviation increase in subsidy intensity led to a 5% rise in sales. However, the adoption rate was still less than 1%. States that implemented incentives saw 211% higher sales growth than those that did not. For electric four-wheelers in the private segment (E4WP), sales grew due to new model launches and consumer demand, but adoption rates remained below 2%. The report highlights the need for continuing support in this segment. The report found that both FAME-I and FAME-II failed to make a statistically significant impact on electric bus (e-bus) adoption. Only 4,766 units were subsidised against a target of 7,262, and the sector continues to face structural barriers such as limited financing access and high upfront costs. 'Coordinated central and state action, pairing targeted purchase incentives, infrastructure rollout, and manufacturing scale-up can help electric cars compete effectively with their counterparts in India's commercial vehicle market,' said Saurabh Trivedi, Sustainable Finance Specialist at IEEFA. The study recommends continued fiscal support, investment in public charging infrastructure, interest rate subvention for buses, and targeted financing support for smaller commercial operators. 'As India transitions from FAME schemes to PM E-DRIVE and other similar initiatives, policymakers must recognise that each EV segment requires tailored intervention,' Konda added. The report draws on panel data of 21,526 observations over 10 years, offering a first-of-its-kind empirical assessment of India's EV subsidy performance using econometric techniques such as difference-in-differences and synthetic control methods.
Hindustan Times
26-05-2025
- Business
- Hindustan Times
BioNext: Generics to biologics, India's moment to lead
Picture this: A cancer patient in a district hospital, once sent abroad for care, now begins treatment with cell therapy—developed and produced just a few hours away, in a domestic biomanufacturing facility. No loud declarations, no sweeping claims--just the quiet signal of a new capability taking root, as India steadily builds a biomanufacturing future from the ground up. India's strength in pharmaceuticals is well known--but what's unfolding now goes beyond low-cost generics and vaccines. With promising advances like the recent approval of India's first indigenous CAR-T cell therapy and successful early-stage gene therapy trials for haemophilia, India is carving out a leadership role on the global stage of biologics. But seizing this opportunity is not guaranteed. It depends on how we build the path ahead. India has the ingredients—future-ready talent base, manufacturing infrastructure, and supportive government initiatives like the Production Linked Incentives and the BioE3 policy. These have laid the foundation, but rising as a leader will demand more: coordination, bold investment, and a focus on capabilities that secure long-term advantage. What could make the difference? First, shaping leadership on two interconnected fronts will be essential: building capacity for next-generation biologic modalities and securing access to the inputs that power them. These biologics--such as cell and gene therapies, monoclonal antibodies, antibody-drug conjugates, and nucleic acid-based treatments--depend on a precise, fast-evolving suite of components. These include everything from expression vectors and viral plasmids to single-use bioprocess components, engineered cell lines, chemical delivery systems, chromatography resins, cytokines, custom enzymes, and purification reagents. A missing reagent or delayed shipment doesn't just slow down a process; it can ground an entire production line. Building production capacity of these inputs—especially near biomanufacturing hubs--will be key to ensuring supply security, operational resilience, lower costs, and faster development timelines. It also advances national self-reliance and positions India as a promising friend-shoring destination for global partners away from high-risk geographies. Second, every stride in biomanufacturing hinges on infrastructure built to enable it. Modular, purpose-built GMP facilities form the backbone of biologics and reagent production. When infrastructure opens its doors, ideas move faster, risks shrink, and the entire biomanufacturing ecosystem grows stronger. Third, new era of biomanufacturing is taking shape—driven by Artificial Intelligence (AI), Machine Learning (ML), robotics, and automation. At its core are large biological language models (LBLMs) reshaping how we engineer biology. Trained on vast biological and process-specific datasets, these AI models and tools are accelerating discovery and transforming bioprocessing—from identifying drug targets and designing novel proteins to optimising leads and streamlining workflows for more scalable, reliable, and error-free production. Fourth, talent will be the X-factor—biomanufacturing's future turns on a specialised workforce trained at the intersection of engineering biology, synthetic biology, bioprocessing, and AI, ML and LBLM. Finally, as advances in engineering biology, synthetic biology, and AI redefine how biologics are discovered, developed, and produced, regulatory systems must evolve too. An agile framework that keeps pace with scientific progress--while aligning with global standards for safety, quality and reliability--can accelerate innovation cycles, increase trust in products, and strengthen the global competitiveness of the biomanufacturing ecosystem. How do we take the lead? Advance and expand future-ready biomanufacturing platforms by supporting both the development of new purpose-built modular facilities and the repurposing of existing biopharma infrastructure through phased adaptation of suitable components. These facilities should function as shared public-private platforms—ensuring sustainability and broad access for start-ups, Contract Development and Manufacturing Organisations (CDMOs), transitioning biomanufacturers, and entrepreneurs relocating operations. Localise supply chains by establishing domestic production capacity for critical reagents and materials within priority manufacturing zones, while incentivising biopharma companies and start-ups to enter this space through targeted support schemes and investment-friendly policies. Establish centralised bio-AI infrastructure through institutionally anchored platforms that give developers access to high-performance computing, well-curated biological datasets, and secure cloud environments. These platforms should serve as national enablers—coordinating with start-ups, pharma companies, CDMOs, and academic partners to collaboratively develop AI models and tools suited to biomanufacturing needs —ranging from models for protein design to simulation tools for optimising cell culture, purification, and quality control. Once in place, this same digital backbone can also support building and deploying AI agents to augment human operation across the biomanufacturing pipeline —from fine-tuning bioprocess conditions and flagging inconsistencies to automating regulatory documentation and forecasting supply needs, these intelligent systems can enhance speed, quality, and consistency throughout production and compliance workflows. Cultivate a robust and future-ready talent pipeline through interdisciplinary training, upskilling programmes, curriculum reforms—supported by strong academia-industry collaboration—at the interface of advanced biomanufacturing disciplines and AI-integrated platforms. Prioritise initiatives for targeted hiring—including efforts to attract Indian postdoctoral researchers and professionals abroad who are seeking meaningful opportunities to return. Invest in scaling domestic capabilities through targeted government instruments such as viability gap funding, low-interest loans, and innovation-linked incentives that reduce early-stage risk. Identify and support entities with the capacity and potential to deliver high-impact products at scale. Modernise regulatory systems to enable risk-proportionate approval pathways, ensure globally benchmarked product quality, enhance biosafety and biosecurity protocols, and achieve world-class compliance to build international product credibility and drive market leadership. With key initiatives already in motion under BIoE3 policy spearheaded by the Department of Biotechnology, pharma companies, CDMOs, and innovators must now build on this momentum—moving beyond legacy products to invest in high-value areas like advanced biologics and critical reagent production. The opportunity is here; the sector is ready. It's time to lead. This article is authored by Dhananjay Kumar Tiwary, Senior Fellow, Brown University, US, and on leave from his position as adviser to the Department of Biotechnology, Government of India.
Yahoo
24-02-2025
- Business
- Yahoo
India Trade Finance Market Trends, Competitive Landscape, Forecasts & Opportunities, 2020-2024 & 2025-2030: Increased Focus on Supply Chain Finance, Expansion of Green and Sustainable Trade Finance
Indian Trade Finance Market Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "India Trade Finance Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to India Trade Finance Market was valued at USD 2.06 Billion in 2024, and is expected to reach USD 3.18 Billion by 2030, rising at a CAGR of 7.56% The India trade finance market is witnessing significant growth, driven by the expansion of international trade, increasing adoption of digital financial services, and government initiatives to promote exports. The rising need for efficient cross-border payment solutions and the growing demand for supply chain financing are further contributing to market expansion. Digitalization and blockchain technology have enhanced transaction transparency and security, streamlining trade processes. Additionally, the government's focus on schemes such as Production Linked Incentives (PLI) and export promotion policies is fostering a favorable environment for trade finance growth, positioning India as a key player in the global trade ecosystem. Increased Focus on Supply Chain FinanceThe growing complexity of global and domestic supply chains has driven the need for efficient supply chain finance solutions in the India trade finance market. Supply chain finance helps businesses maintain cash flow by providing early payment options to suppliers while allowing buyers extended payment terms. This financial tool has become particularly valuable as companies seek to stabilize their operations and mitigate risks in response to supply chain disruptions.E-commerce companies, FMCG businesses, and manufacturing firms are increasingly leveraging supply chain finance to enhance procurement efficiency and strengthen supplier relationships. Banks and financial institutions are also developing customized supply chain financing products to cater to diverse industry needs. With the rise of digital supply chain platforms and integration of data analytics, supply chain finance is becoming a critical growth driver for the trade finance market in of Green and Sustainable Trade FinanceAs sustainability becomes a key focus for businesses worldwide, green and sustainable trade finance is gaining momentum in India. Companies are increasingly seeking financial products that support environmentally and socially responsible trade practices. Green trade finance solutions, including loans and guarantees for eco-friendly projects, are emerging as a significant trend in the institutions are now incorporating environmental, social, and governance (ESG) criteria into their trade finance offerings to promote sustainability. Government initiatives encouraging the adoption of green technologies and sustainable business practices are further driving this trend. With India's commitment to reducing carbon emissions and adopting clean energy sources, the demand for green trade finance solutions is expected to grow in the coming yearService Provider InsightsBanks dominated the India trade finance market, playing a crucial role in facilitating domestic and international trade transactions. They provide a wide range of financial services, including letters of credit, bank guarantees, and trade loans, ensuring secure and efficient payment mechanisms for businesses. Leading public and private sector banks have extensive networks and deep industry expertise, making them preferred partners for trade finance. Their adoption of digital platforms has further streamlined trade processes, enhancing transaction speed and transparency. Additionally, regulatory support and partnerships with fintech companies have strengthened banks' capabilities, solidifying their dominance in the trade finance InsightsThe North region dominated the India trade finance market, driven by its strong industrial base and robust trade activities. States like Delhi, Haryana, Uttar Pradesh, and Punjab contribute significantly due to their thriving manufacturing, export-oriented industries, and well-established supply chains. The region's strategic proximity to international trade routes and major ports enhances its trade finance ecosystem. Additionally, government initiatives and infrastructure development in key industrial zones have further strengthened trade activities. Financial institutions in the region actively provide trade finance solutions to support large-scale businesses, making the North region a critical hub for trade finance in India. Report Scope: Key Market Players SBM Bank (India) Ltd. HDFC Bank Limited Yes Bank Limited Standard Chartered Group Kotak Mahindra Bank Limited The Federal Bank Limited Hongkong and Shanghai Banking Corporation Limited Terkar Global Financial Development Pvt Ltd. Axis Bank Limited Bank of Baroda India Trade Finance Market, By Product Type: Letters of Credit Export Factoring Insurance Bill of Lading Guarantees Others India Trade Finance Market, By Service Provider: Banks Trade Finance Houses Others India Trade Finance Market, By Application: Domestic International India Trade Finance Market, By Region: North South East West Key Attributes: Report Attribute Details No. of Pages 81 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $2.06 Billion Forecasted Market Value (USD) by 2030 $3.18 Billion Compound Annual Growth Rate 7.5% Regions Covered India For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Indian Trade Finance Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
